Reports of suspected counterfeiting, which can be traced back to technical problems, do not only appear in the securPharm system. The Austrian system of the Austrian Medicines Verification Organisation (AMVO) therefore provides for a stabilization period of six months. There is also concern in Austria that after the start of the national system AMVS (Germay: […]
Read More… from Stabilisation Period in Austria: Good Information Policy for Error Messages
securPharm false alarm reports occupy Federal Ministry of Health […]
Read More… from securPharm False Reports Occupy Federal Ministry of Health
The securPharm launch is approaching in big steps and yet there still seem to be problems with the current tests of the securPharm system. Both pharmacies and pharmaceutical companies are reporting problems. In a crisis meeting on the occasion of the securPharm start (29.01.2019) of the relevant associations, problems were addressed with the upload of […]
Read More… from Start-up Problems at securPharm – tracekey Customers Feel Well Supported
In pharmacies, hundreds of medicines are sold every day. From 9 February 2019, all prescription drugs must be serialized. So what does the Falsified Medicines Directive (FMD) mean for pharmacies and their internal processes? Pharmacies usually purchase their medicines from wholesalers, where individual packagings can be checked optional. In the pharmacy every single medicine pack […]
Read More… from Serialization for pharmacies – what changes in everyday life?
Hospitals work with a large number of Rx drugs on a daily basis, in addition, processes are closely timed. So how will the Falsified Medicines Directive affect hospital pharmacies? The Falsified Medicines Directive (FMD) stipulates that every prescription-only drug in hospital pharmacies must be scanned and verified via the database. The Bundesverband Deutscher Krankenhausapotheken (ADKA), […]
Read More… from Serialization for hospitals – what changes in everyday life?
Traceability and a transparent supply chain play a key role in many industries. The pharmaceutical industry can act as a role model. Central to this is always the question of the origin of a product, as well as a secure and traceable path from the producer to the consumer. The pharmaceutical industry tries to summarize […]
Read More… from Is the pharmaceutical industry a role model for other industries?
The primary objective of serialization is to protect patients. This is enabled by processes and control mechanisms that ensure that only original and manufacturer-approved drugs reach pharmacies and hospitals. But what are the benefits of serialization in pharma? In this article we show you how serialization improves sustainability, trust and safety. Sustainable changes in almost […]
With the publication of the Delegated Regulation (EU) 2016/161 in the Official Journal of the European Union, the deadline for transposition of the new EU Counterfeiting Directive has been set. Beginning on 9.2.2019, prescription drugs must be clearly identifiable and traceable – every single package. EU Counterfeiting Directive: Increasing drug safety for consumers Antibiotics, anticancer […]
Read More… from What effect does the EU directive have on the pharmaceutical industry?